2008 annual financial data
Summit Therapeutics 2008 Operating margin
Direct answer
Operating margin was -7,198.87%.
Operating income was -19,195,000 GBP and net income was -32,289,000 GBP.
Operating cash flow was -14,721,397 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 266,639 GBP
- Operating income
- -19,195,000 GBP
- Net income
- -32,289,000 GBP
- Operating cash flow
- -14,721,397 GBP